Shu Zhang

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID

Publications

Citations

Est. group size

—

Recurring co-author estimate

Active years

Publishing since 2021

Research summary

AI-generated

Shu Zhang studies the molecular and epigenetic mechanisms that drive cancer, with a focus on how chemical modifications to DNA (epigenetics) influence tumor behavior. Recent work examines ovarian cancer, including how blocking DNA methylation enzymes affects cancer stem cells and immune-signaling pathways, as well as gene regulation in bladder cancer. The research combines cancer biology, gene regulation, and immune response themes.

Cancer molecular mechanismsEpigenetics and DNA methylationGene regulation in cancerImmune signaling pathwaysOvarian and bladder cancer

Publication activity has grown markedly in the most recent years, with a notable increase in output from 2024 onward after little earlier activity.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence

Publications per year over the last 10 years — averaging 3.6/year recently

Recent publications

DNA Methyltransferase Inhibition Prevents Platinum-Induced Ovarian Cancer Stem Cell Enrichment
Cancer Research Communications · 2026
Abstract 4844: Epigenetic reprogramming of the STING pathway as a combination strategy in high grade serous ovarian cancer
Cancer Research · 2025
Long noncoding RNA OIP5-AS1 exhibits oncogenic activity in bladder cancer through miR-217 and MTDH
DOAJ (DOAJ: Directory of Open Access Journals) · 2021

Publishes in

Cancer Research×3
Molecular Cancer Therapeutics×1
DOAJ (DOAJ: Directory of Open Access Journals)×1
Cancer Research Communications×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile